Citations (6)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Bennett Allen, Michelle L. Nolan & Denise Paone. (2019) Underutilization of medications to treat opioid use disorder: What role does stigma play?. Substance Abuse 40:4, pages 459-465.
Read now
Read now
Florence Vorspan, Peter Hjelmström, Nicolas Simon, Amine Benyamina, Alain Dervaux, Georges Brousse, Thierry Jamain, Margaux Kosim & Benjamin Rolland. (2019) What place for prolonged-release buprenorphine depot-formulation Buvidal® in the treatment arsenal of opioid dependence? Insights from the French experience on buprenorphine. Expert Opinion on Drug Delivery 16:9, pages 907-914.
Read now
Read now
Xiaofan Li, Daryl Shorter & Thomas R Kosten. (2014) Buprenorphine in the treatment of opioid addiction: opportunities, challenges and strategies. Expert Opinion on Pharmacotherapy 15:15, pages 2263-2275.
Read now
Read now
Articles from other publishers (3)
Qi Guan, Wayne Khuu, Sheryl Spithoff, Tara Kiran, Meldon Kahan, Mina Tadrous, Diana Martins, Pamela Leece & Tara Gomes. (2017) Patterns of physician prescribing for opioid maintenance treatment in Ontario, Canada in 2014. Drug and Alcohol Dependence 177, pages 315-321.
Crossref
Crossref
George E. Woody. (2017) Advances in the treatment of opioid use disorders. F1000Research 6, pages 87.
Crossref
Crossref
Jens Reimer, Nat Wright, Lorenzo Somaini, Carlos Roncero, Icro Maremmani, Neil McKeganey, Richard Littlewood, Peter Krajci, Hannu Alho & Oscar D''Agnone. (2016) The Impact of Misuse and Diversion of Opioid Substitution Treatment Medicines: Evidence Review and Expert Consensus. European Addiction Research 22:2, pages 99-106.
Crossref
Crossref